United States

Propanc Biopharma Inc (PPCH)

Track

Track

Ticker: PPCH
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Nathanielsz James Andrew Chief Executive Officer Executive Director Large shareholder
Transaction date
Sale
Price
354.31
Quantity 36,654 +47.1%
Value US$509,011
Nathanielsz James Andrew Chief Executive Officer Executive Director Large shareholder
Transaction date
Sale
Price
294.61
Quantity 38,066 +46.3%
Value US$1,743,010
Nathanielsz James Andrew Chief Executive Officer Executive Director Large shareholder
Transaction date
Sale
Price
101.85
Quantity 68,722 +47.9%
Value US$2,859,180
Nathanielsz James Andrew Chief Executive Officer Executive Director Large shareholder
Transaction date
Sale
Price
0.20
Quantity 5,000 -0.1%
Value US$1,000
Nathanielsz James Andrew Chief Executive Officer Executive Director Large shareholder
Transaction date
Sale
Price
0.20
Quantity 250,000 -2.5%
Value US$50,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2015-01-13 2013-07-05 S Sale Nathanielsz James Andrew

Chief Executive Officer

Executive Director Large shareholder
36,654 +47.1%
354.31
US$509,011 		36,654 +47.1% 354.31 US$509,011
2015-01-13 2013-01-23 S Sale Nathanielsz James Andrew

Chief Executive Officer

Executive Director Large shareholder
38,066 +46.3%
294.61
US$1,743,010 		38,066 +46.3% 294.61 US$1,743,010
2015-01-13 2012-12-13 S Sale Nathanielsz James Andrew

Chief Executive Officer

Executive Director Large shareholder
68,722 +47.9%
101.85
US$2,859,180 		68,722 +47.9% 101.85 US$2,859,180
2015-01-13 2012-09-14 S Sale Nathanielsz James Andrew

Chief Executive Officer

Executive Director Large shareholder
5,000 -0.1%
0.20
US$1,000 		5,000 -0.1% 0.20 US$1,000
2015-01-13 2012-09-04 S Sale Nathanielsz James Andrew

Chief Executive Officer

Executive Director Large shareholder
250,000 -2.5%
0.20
US$50,000 		250,000 -2.5% 0.20 US$50,000
Explore more

More insider trading research around Propanc Biopharma Inc

More insider trades in United States
Insider trading in North America